ATE48642T1 - Klonierungs- oder expressionsvektoren die das genom vom gefluegel-erythroblastosenvirus enthalten und durch diese vektoren transfektierte zellen. - Google Patents

Klonierungs- oder expressionsvektoren die das genom vom gefluegel-erythroblastosenvirus enthalten und durch diese vektoren transfektierte zellen.

Info

Publication number
ATE48642T1
ATE48642T1 AT85401999T AT85401999T ATE48642T1 AT E48642 T1 ATE48642 T1 AT E48642T1 AT 85401999 T AT85401999 T AT 85401999T AT 85401999 T AT85401999 T AT 85401999T AT E48642 T1 ATE48642 T1 AT E48642T1
Authority
AT
Austria
Prior art keywords
cloning
genome
poultry
cells transfected
vectors
Prior art date
Application number
AT85401999T
Other languages
English (en)
Inventor
Jacques Samarut
Gerard Verdier
Miloud Benchaibi
Pierre Savatier
Didier Poncet
Frederic Flamant
Jiao-Hao Xiao
Pierrick Thoraval
Frederique Chambonnet
Victor Nigon
Original Assignee
Agronomique Inst Nat Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agronomique Inst Nat Rech filed Critical Agronomique Inst Nat Rech
Application granted granted Critical
Publication of ATE48642T1 publication Critical patent/ATE48642T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT85401999T 1984-10-15 1985-10-15 Klonierungs- oder expressionsvektoren die das genom vom gefluegel-erythroblastosenvirus enthalten und durch diese vektoren transfektierte zellen. ATE48642T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8415764A FR2571737B1 (fr) 1984-10-15 1984-10-15 Vecteurs de clonage ou d'expression comportant le genome du virus de l'erythroblastose aviaire et cellules transfectees par ces vecteurs
EP85401999A EP0178996B1 (de) 1984-10-15 1985-10-15 Klonierungs- oder expressionsvektoren die das Genom vom Geflügel-Erythroblastosenvirus enthalten und durch diese Vektoren transfektierte Zellen

Publications (1)

Publication Number Publication Date
ATE48642T1 true ATE48642T1 (de) 1989-12-15

Family

ID=9308658

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85401999T ATE48642T1 (de) 1984-10-15 1985-10-15 Klonierungs- oder expressionsvektoren die das genom vom gefluegel-erythroblastosenvirus enthalten und durch diese vektoren transfektierte zellen.

Country Status (16)

Country Link
US (1) US4957865A (de)
EP (1) EP0178996B1 (de)
JP (1) JPS62501398A (de)
AT (1) ATE48642T1 (de)
AU (1) AU5010585A (de)
BR (1) BR8506990A (de)
DE (1) DE3574732D1 (de)
DK (1) DK279686D0 (de)
ES (2) ES8900170A1 (de)
FI (1) FI862517A0 (de)
FR (1) FR2571737B1 (de)
GR (1) GR852500B (de)
NO (1) NO862383L (de)
PT (1) PT81306B (de)
WO (1) WO1986002380A1 (de)
ZA (1) ZA857862B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1310924C (en) * 1986-04-24 1992-12-01 Francis P. Mccormick Infective drug delivery system
FR2606030B1 (fr) * 1986-10-31 1989-10-20 Pasteur Institut Retrovirus recombinant defectif, son procede de fabrication et ses applications, notamment pour l'etude de l'interaction des retrovirus sauvages avec des lignees cellulaires infectables par celui-ci
US5256553A (en) * 1987-10-09 1993-10-26 Immunex Corporation Multiple promoter transforming retroviral vectors
FR2622207B1 (fr) * 1987-10-21 1990-03-09 Agronomique Inst Nat Rech Vecteurs d'integration et d'expression d'un gene heterologue, cellules infectees avec ces vecteurs et procede de production d'une proteine ou de modification genetique d'animaux
FR2631974B1 (fr) * 1988-05-31 1992-12-11 Agronomique Inst Nat Rech Baculovirus modifie, son procede de preparation et son application en tant que vecteur d'expression de genes
US6027722A (en) * 1990-10-25 2000-02-22 Nature Technology Corporation Vectors for gene transfer
EP0506945B1 (de) * 1990-10-25 1998-07-29 HODGSON, Clague Pitman Methode des gentransfers mittels retrotransposons
US6300058B1 (en) * 1992-01-29 2001-10-09 Hitachi Chemical Research Center, Inc. Method for measuring messenger RNA
WO1994020608A1 (en) 1993-03-12 1994-09-15 Creighton University Improved vectors for gene therapy
US5808043A (en) * 1995-01-18 1998-09-15 Pharmacia Biotech Inc. Composition for stabilization of labelled nucleoside triphosphates and methods for using same
US20030190753A1 (en) * 1995-11-09 2003-10-09 Nature Technology Corporation Vectors for gene transfer
WO2000029444A1 (en) * 1998-11-16 2000-05-25 Genway Biotech, Inc. Generation of antibodies using polynucleotide vaccination in avian species
US20070082354A1 (en) * 2005-09-26 2007-04-12 Nexttec Gmbh Method for Isolating RNA

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405712A (en) * 1981-07-01 1983-09-20 The United States Of America As Represented By The Department Of Health And Human Services LTR-Vectors
EP0105141A3 (de) * 1982-09-09 1985-12-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Rekombinante DNS Moleküle, Verfahren zu deren Herstellung, deren Verwendung zur Herstellung von Hepatitis B Oberflächen-Antigen (HBsAg) und pharmazeutische Zusammensetzungen die das HBsAg enthalten
FR2559159B1 (fr) * 1984-02-02 1986-09-12 Inst Nat Sante Rech Med Vecteurs viraux de clonage et d'expression d'une proteine dans une cellule eucaryote, comportant au moins une partie du genome d'un retro-virus; cellules eucaryotes transfectees; procede utilisant de telles cellules et proteines obtenues
US4686098A (en) * 1984-05-14 1987-08-11 Merck & Co., Inc. Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo

Also Published As

Publication number Publication date
NO862383D0 (no) 1986-06-16
ES557463A0 (es) 1987-12-16
FR2571737B1 (fr) 1987-02-20
US4957865A (en) 1990-09-18
EP0178996B1 (de) 1989-12-13
FI862517A (fi) 1986-06-12
ES548529A0 (es) 1988-04-16
ES8900170A1 (es) 1988-04-16
EP0178996A1 (de) 1986-04-23
FR2571737A1 (fr) 1986-04-18
AU5010585A (en) 1986-05-02
PT81306B (fr) 1987-03-25
DK279686A (da) 1986-06-13
DE3574732D1 (de) 1990-01-18
ES8800985A1 (es) 1987-12-16
NO862383L (no) 1986-06-16
FI862517A0 (fi) 1986-06-12
BR8506990A (pt) 1987-01-06
ZA857862B (en) 1986-05-28
GR852500B (de) 1986-02-18
JPS62501398A (ja) 1987-06-11
WO1986002380A1 (fr) 1986-04-24
DK279686D0 (da) 1986-06-13
PT81306A (fr) 1985-11-01

Similar Documents

Publication Publication Date Title
ATE48642T1 (de) Klonierungs- oder expressionsvektoren die das genom vom gefluegel-erythroblastosenvirus enthalten und durch diese vektoren transfektierte zellen.
ATE175997T1 (de) Behandlung von zellpopulationen
ATE322547T1 (de) Adenovirale vektoren für die behandlung der hämophilie
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
DK0591914T4 (da) Retrovirus fra HIV-gruppen og dets anvendelse
DE3783282D1 (de) Varianten von lav-viren, deren dns- und proteinkomponenten und deren verwendung, insbesondere zu diagnostischen zwecken und zur herstellung von immunogenen zusammensetzungen.
DE69435303D1 (de) Er behandlung von krankheiten bei denen eine cytok
ATE228569T1 (de) Defekte verpackende nicht-oncoviren vektoren aus mpmv
ATE364717T1 (de) Diagnose durch bestimmung von polymorphismen in der promoterregion des tgf-beta 1 gens
ATE26710T1 (de) Substituierte tert.-butanol-derivate, verfahren zu ihrer herstellung und diese enthaltende antimykotische mittel.
ATE172470T1 (de) Für den interleukin-9-rezeptor kodierende nukleinsäuresequenzen bzw. dafür komplementäre nuleinsäuresequenzen
DE69940793D1 (de) Chimärisches Gen, dass für die antigenischen Determinanten von vier Proteinen aus L. Infantum kodiert
ATE47864T1 (de) Verschiedenartige familie von menschlichen leukozyten-interferonen, zusammensetzungen, die diese enthalten, verfahren zu ihrer herstellung, sowie dna und transfektierte wirte hierfuer.
ATE103980T1 (de) Das f-protein vom aids-virus enthaltender impfstoff.
DE69800966D1 (de) Spermaverdünner der natives phosphocaseinat oder beta lactoglobulin enthält, verfahren zu seiner herstellung und seine verwendungen
FI840104A (fi) Rekombinant-dna-expressionsvektorer anvaendbara i bacillus- och andra vaerdceller.
ATE352635T1 (de) Nukleotidsequenz, die für eine flavinmonooxygenase kodiert, das korrespondierende protein, sowie deren verwendungen in diagnostik und therapie
Rushbrook et al. Myosin light chain-1: Genetic analysis of three variants found in fast white chicken muscle and investigation of linkage with the muscular dystrophy gene
KR910004802A (ko) 긴팔원숭이 백혈병 비루스 리셉터 단백질, 이를 암호화하는 단리된 정제 dna 서열 및 이들을 동정하는 방법
Wippel Quidditative Knowledge of God According to Thomas Aquinas
DE3866451D1 (de) Zur verhinderung von quecksilbervergiftungen, hervorgerufen durch abspaltung des quecksilbers aus amalgamfuellungen, bestimmte zusammensetzung.
Bard et al. Sequence and genomic locus of a Leishmania protein homologous to rat ribosomal protein S8.
Tomaszewska-Guszkiewicz et al. Transferrin polymorphism in some breeds and types of horses, reared in Poland
ATE124722T1 (de) Für das plazentaprotein 9 (pp9) kodierende cdna, ihre isolierung und verwendung.
DE3677436D1 (de) Reinigung des blutgerinnungsfaktors-viii durch faellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee